Indonesia Jadi Negara Uji Coba Vaksin TBC, Warga Bukan 'Kelinci Percobaan' - [Metro Siang]

Summary

Indonesia has recruited 2,095 participants for phase 3 clinical trials of the M72 tuberculosis vaccine, developed by the Bill & Melinda Gates Foundation. This vaccine, currently in the final trial stage, is also being tested in countries like South Africa, Kenya, Zambia, and Malawi. The Health Minister reassures the public that the vaccine is safe, as it has already passed earlier trial phases. With Indonesia contributing to global efforts, the new vaccine aims to combat tuberculosis, which remains a major health concern, especially as the current TB vaccine is over 100 years old. The government urges the public to follow official updates and combat misinformation surrounding the trials.

Takeaways

• 😀 Indonesia is participating in a global clinical trial for the M72 tuberculosis vaccine, funded by the Gates Foundation.
• 😀 The clinical trial for the M72 vaccine is in its third and final phase, which assesses its effectiveness before potential widespread use.
• 😀 2,095 participants from Indonesia, ranging from teenagers to adults, are involved in the trial.
• 😀 The M72 vaccine has already passed Phase 1 and 2 clinical trials, assuring the public of its safety.
• 😀 The vaccine trial is conducted across several countries, including South Africa, Kenya, Zambia, and Malawi.
• 😀 Tuberculosis (TB) is a contagious disease caused by the Mycobacterium tuberculosis bacteria, affecting organs like the lungs, spine, brain, and heart.
• 😀 Indonesia is the second-largest contributor to global TB cases, accounting for 10% of worldwide TB cases.
• 😀 Current TB vaccines have been in use since 1921, making the M72 vaccine a critical step in improving TB prevention.
• 😀 The Indonesian government plans to locally produce the M72 vaccine through Biofarma if the trials succeed.
• 😀 Health authorities urge the public to dismiss rumors and misinformation, emphasizing the safety of the M72 vaccine based on scientific evidence from the trials.

Q & A

What is the purpose of the clinical trial discussed in the script?

The clinical trial is testing the effectiveness and safety of the M72 tuberculosis vaccine, which is in its Phase 3 trials before it can be widely used.

Who is funding the M72 tuberculosis vaccine development?

The M72 tuberculosis vaccine is being developed with support from the Gates Foundation, founded by Bill Gates.

How many participants is Indonesia recruiting for the clinical trial?

Indonesia is recruiting 2,095 participants from both adolescent and adult age groups for the clinical trial.

In which other countries is the M72 tuberculosis vaccine being tested?

In addition to Indonesia, the M72 vaccine is being tested in South Africa, Kenya, Zambia, and Malawi.

What is the current stage of the M72 vaccine in the clinical trial process?

The M72 vaccine is currently in Phase 3 of the clinical trial, which is the final stage before it can be used widely.

Why is the development of a new tuberculosis vaccine necessary?

A new vaccine is needed because the current tuberculosis vaccine has been in use since 1921, making it over 100 years old, and there are still global challenges in controlling TB.

What are some common symptoms of tuberculosis (TB)?

Common symptoms of tuberculosis include a persistent cough, coughing up phlegm, weight loss, night sweats, chest pain, shortness of breath, and high fever.

What are the global statistics regarding tuberculosis cases mentioned in the script?

India has the highest number of TB cases, contributing to 26% of global cases. Indonesia ranks second with 10% of the global cases, followed by China (6.8%), the Philippines (6.8%), and Pakistan (6.3%).

What precautions are being taken regarding the safety of the vaccine in Indonesia?

The Indonesian government has assured the public that the vaccine has already undergone Phase 1 and Phase 2 trials, and the ongoing Phase 3 trials will confirm its safety and effectiveness.

What organizations are involved in the tuberculosis vaccine clinical trial?

The clinical trial involves several organizations, including the World Health Organization (WHO), the National Drug and Food Control Agency (BPOM), the Ministry of Health of Indonesia, as well as global and national vaccine experts and institutions like Universitas Indonesia and Universitas Pajajaran.